Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker IPSC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 266 | $1.52 | $404 Sale | Form 4 ↗ |
| Sep 14, 2026 | Gregory Russotti See Remarks | IPSC Century Therapeutics, Inc. | Sale | 2,587 | $1.93 | $4,993 Sale | Form 4 ↗ |
| Sep 14, 2026 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 1,658 | $1.93 | $3,200 Sale | Form 4 ↗ |
| Sep 8, 2026 | Gregory Russotti See Remarks | IPSC Century Therapeutics, Inc. | Sale | 534 | $2.05 | $1,095 Sale | Form 4 ↗ |
| Sep 8, 2026 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 254 | $2.05 | $521 Sale | Form 4 ↗ |
| Aug 3, 2026 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 275 | $1.98 | $545 Sale | Form 4 ↗ |
| Jun 12, 2026 | Gregory Russotti See Remarks | IPSC Century Therapeutics, Inc. | Sale | 2,584 | $2.23 | $5,762 Sale | Form 4 ↗ |
| Jun 12, 2026 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 1,654 | $2.23 | $3,688 Sale | Form 4 ↗ |
| Jun 8, 2026 | Gregory Russotti See Remarks | IPSC Century Therapeutics, Inc. | Sale | 524 | $2.11 | $1,106 Sale | Form 4 ↗ |
| Jun 8, 2026 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 249 | $2.11 | $525 Sale | Form 4 ↗ |
| May 4, 2026 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 264 | $2.34 | $618 Sale | Form 4 ↗ |
| Mar 12, 2026 | Gregory Russotti See Remarks | IPSC Century Therapeutics, Inc. | Sale | 10,076 | $2.55 | $25.7K Sale | Form 4 ↗ |
| Mar 12, 2026 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 7,043 | $2.55 | $18.0K Sale | Form 4 ↗ |
| Mar 9, 2026 | Gregory Russotti See Remarks | IPSC Century Therapeutics, Inc. | Sale | 479 | $2.54 | $1,217 Sale | Form 4 ↗ |
| Mar 9, 2026 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 247 | $2.54 | $627 Sale | Form 4 ↗ |
| Feb 3, 2026 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 323 | $1.82 | $588 Sale | Form 4 ↗ |
| Dec 22, 2025 | Chad Cowan Chief Scientific Officer | IPSC Century Therapeutics, Inc. | Buy | 58,060 | $0.85 | $49.4K Buy | Form 4 ↗ |
| Dec 12, 2025 | Brent Pfeiffenberger President and CEO, Director | IPSC Century Therapeutics, Inc. | Buy | 52,000 | $0.58 | $30.2K Buy | Form 4 ↗ |
| Dec 8, 2025 | Gregory Russotti See Remarks | IPSC Century Therapeutics, Inc. | Sale | 526 | $0.53 | $279 Sale | Form 4 ↗ |
| Dec 8, 2025 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 257 | $0.53 | $136 Sale | Form 4 ↗ |
| Nov 20, 2025 | Chad Cowan Chief Scientific Officer | IPSC Century Therapeutics, Inc. | Sale | 5,462 | $0.50 | $2,731 Sale | Form 4 ↗ |
| Nov 19, 2025 | Brent Pfeiffenberger President and CEO, Director | IPSC Century Therapeutics, Inc. | Buy | 35,000 | $0.50 | $17.5K Buy | Form 4 ↗ |
| Nov 17, 2025 | Brent Pfeiffenberger President and CEO, Director | IPSC Century Therapeutics, Inc. | Sale | 32,456 | $0.45 | $14.6K Sale | Form 4 ↗ |
| Nov 3, 2025 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 292 | $0.59 | $172 Sale | Form 4 ↗ |
| Sep 8, 2025 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 263 | $0.50 | $132 Sale | Form 4 ↗ |
| Sep 8, 2025 | Brent Pfeiffenberger President and CEO, Director | IPSC Century Therapeutics, Inc. | Sale | 488 | $0.50 | $244 Sale | Form 4 ↗ |
| Sep 8, 2025 | Gregory Russotti See Remarks | IPSC Century Therapeutics, Inc. | Sale | 539 | $0.50 | $270 Sale | Form 4 ↗ |
| Aug 4, 2025 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 296 | $0.53 | $157 Sale | Form 4 ↗ |
| Jun 9, 2025 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 4,904 | $0.62 | $3,040 Sale | Form 4 ↗ |
| Jun 9, 2025 | Adrienne Farid Chief Operations Officer | IPSC Century Therapeutics, Inc. | Sale | 552 | $0.62 | $342 Sale | Form 4 ↗ |
| Jun 9, 2025 | Brent Pfeiffenberger President and CEO, Director | IPSC Century Therapeutics, Inc. | Sale | 475 | $0.62 | $295 Sale | Form 4 ↗ |
| Jun 9, 2025 | Gregory Russotti See Remarks | IPSC Century Therapeutics, Inc. | Sale | 526 | $0.62 | $326 Sale | Form 4 ↗ |
| May 16, 2025 | Brent Pfeiffenberger President and CEO, Director | IPSC Century Therapeutics, Inc. | Sale | 29,552 | $0.55 | $16.3K Sale | Form 4 ↗ |
| May 5, 2025 | Adrienne Farid Chief Operations Officer | IPSC Century Therapeutics, Inc. | Sale | 1,024 | $0.55 | $563 Sale | Form 4 ↗ |
| May 5, 2025 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 295 | $0.55 | $162 Sale | Form 4 ↗ |
| Mar 10, 2025 | Brent Pfeiffenberger President and CEO, Director | IPSC Century Therapeutics, Inc. | Sale | 2,235 | $0.62 | $1,386 Sale | Form 4 ↗ |
| Mar 10, 2025 | Gregory Russotti See Remarks | IPSC Century Therapeutics, Inc. | Sale | 2,360 | $0.62 | $1,463 Sale | Form 4 ↗ |
| Mar 10, 2025 | Adrienne Farid Chief Operations Officer | IPSC Century Therapeutics, Inc. | Sale | 2,359 | $0.62 | $1,463 Sale | Form 4 ↗ |
| Mar 10, 2025 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 1,240 | $0.62 | $769 Sale | Form 4 ↗ |
| Feb 18, 2025 | Brent Pfeiffenberger President and CEO, Director | IPSC Century Therapeutics, Inc. | Sale | 34,712 | $0.78 | $27.1K Sale | Form 4 ↗ |
| Feb 3, 2025 | Adrienne Farid Chief Operations Officer | IPSC Century Therapeutics, Inc. | Sale | 1,054 | $0.78 | $822 Sale | Form 4 ↗ |
| Feb 3, 2025 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 351 | $0.78 | $274 Sale | Form 4 ↗ |
| Nov 4, 2024 | Adrienne Farid Chief Operations Officer | IPSC Century Therapeutics, Inc. | Sale | 1,033 | $1.23 | $1,271 Sale | Form 4 ↗ |
| Nov 4, 2024 | Douglas Carr SVP Finance & Operations | IPSC Century Therapeutics, Inc. | Sale | 283 | $1.23 | $348 Sale | Form 4 ↗ |
44 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:22 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances